CrushSCI.com
104.4Average days
91Median days
19Fastest days
203Longest days
2272025 publications

Paper Review Records

All Paper Review Records

27 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

159 days

Immune reconstitution and clinical outcomes in B-ALL patients with versus without pre-HSCT Immunotherapy

Authors
Yu-Yuan Zeng; Guan-Hua Hu; Ying-Xi Zuo; Pan Suo; Lu Bai; Feng Zhang; Hui-Fang Wang; Ying-Jun Chang; Meng Lv; Xiao-Hui Zhang; Yu Wang; Lan-Ping Xu; Xiao-Jun Huang; Lin Wang; Yi-Fei ChengShow moreShow less
Affiliations
1. Department of Child Health Care, Capital Center for Children’s Health, Capital Medical University, Beijing, China; 2. Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, ChinaShow moreShow less
Source PDF DOI Publisher page
148 days

Final analysis results from DREAMM-3, a phase 3 study of belantamab mafodotin versus pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma

Authors
Meletios Athanasios Dimopoulos; Vania Hungria; Haitao Meng; Atanas Radinoff; Jian Li; Sosana Delimpasi; Ting Niu; Gabor Mikala; Tamas Masszi; Marcelo Capra; Michael Low; Angelo Maiolino; Yan Xu; Xavier Leleu; Vasiliki Pappa; Dominik Chraniuk; Tatiana Konstantinova; Iurii Osipov; Shawn Hakim; Chris Brawley; Gabriela Tubel; Astrid McKeown; Julia Boyle; Sumita Roy-Ghanta; Katja WeiselShow moreShow less
Affiliations
1. National and Kapodistrian University of Athens, Athens, Greece; 2. Korea University, Seoul, South Korea; 3. Department of Hematology, Clinica São Germano São Paulo, São Paulo, Brazil; 4. The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 5. University Hospital “St Ivan Rilski” EAD, Sofia, Bulgaria; 6. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 7. General Hospital Evangelismos, Athens, Greece; 8. West China Hospital of Sichuan University, Chengdu, China; 9. South Pest Central Hospital, National Institute for Haematology and Infectious Diseases, Budapest, Hungary; 10. Semmelweis University Department of Internal Medicine and Hematology, Budapest, Hungary; 11. Centro Gaúcho Integrado de Pesquisa, Hospital Mãe de Deus, Porto Alegre, Brazil; 12. Monash Haematology, Monash University, Clayton University, Victoria, Australia; 13. Instituto Americas de Ensino, Pesquisa e Inovacao, Rio de Janeiro, Brazil; 14. Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 15. Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China; 16. Hospital of Poitiers, Poitiers, France; 17. Second Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital “Attikon”, Athens, Greece; 18. Department of Hematology, Wojewodzki Szpital Zespolony, Torun, Poland; 19. Regional Clinical Hospital No 1, Ekaterinburg, Russian Federation; 20. V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation; 21. GSK, Upper Providence, USA; 22. GSK, London, UK; 23. GSK, Stevenage, UK; 24. University Medical Center of Hamburg-Eppendorf, Hamburg, GermanyShow moreShow less
Source PDF DOI Publisher page
79 days

Improving survival and narrowing age disparities in mantle cell lymphoma across therapeutic eras

Authors
Malak Munir; John L. Vaughn; Sravani Rimmalapudi; Narendranath EpperlaShow moreShow less
Affiliations
1. Department of Medicine, Rochester General Hospital, Rochester, USA; 2. Division of Hematology & Oncology, Westchester Medical Center, Valhalla, USA; 3. Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, USAShow moreShow less
Source PDF DOI Publisher page
128 days

Glucagon-like peptide-1 receptor agonists and risk for hematologic malignancies: a multicenter propensity score-matched analysis

Authors
Pratik Shah; Adit Singhal; Tsu Hsien Wang; Albert Ko; Yu-Cheng Chang; Anita Ng; Andrew Shih; Yuan Ping Hsia; Cho-Hung Chiang; Cho-Han ChiangShow moreShow less
Affiliations
1. Northwell Health Cancer Institute, Lake Success, USA; 2. Department of Medicine, University at Buffalo-Catholic Health System, Buffalo, USA; 3. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA; 4. Department of Medicine, Danbury Hospital, Danbury, USA; 5. Feinstein Institutes for Medical Research, Manhasset, USA; 6. Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; 7. Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanShow moreShow less
Source PDF DOI Publisher page
114 days

A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma

Authors
Ricardo Ahrens; Kyra Ahrens; Maximilian Al-Bazaz; Lisa Leypoldt; Carsten Bokemeyer; Winfried Alsdorf; Katja WeiselShow moreShow less
Affiliations
1. Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2. Knowledge Technology Group, Department of Informatics, University of Hamburg, Hamburg, GermanyShow moreShow less
Source PDF DOI Publisher page
79 days

Clinicomolecular features and clonal evolution of KMT2A -PTD AML: prognostic impact of concurrent FLT3 -ITD under 2022 ELN risk stratification

Authors
Yi-Tsung Yang; Chi-Yuan Yao; Yong-Huai Yi; Chein-Jun Kao; Yuan-Yeh Kuo; Ming-En Lin; Hsin-An Hou; Chien-Chin Lin; Wen-Chien Chou; Hwei-Fang TienShow moreShow less
Affiliations
1. Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; 2. Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; 3. Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 4. Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan; 5. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan; 6. Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei City, TaiwanShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.